Brief: Endra Life Sciences Entered Into An At-The-Market Issuance Sales Agreement Relating To Offer And Sale Of Up To $6.2 Million Of Our Common Stock
03/04/2024 22:19
April 3 (Reuters) - ENDRA Life Sciences Inc NDRA.O :
* ENDRA LIFE SCIENCES INC - ENTERED INTO AN AT-THE-MARKET
ISSUANCE SALES AGREEMENT RELATING TO OFFER AND SALE OF UP TO
$6.2 MILLION OF OUR COMMON STOCK
Source text for Eikon: ID:n0001654954-24-004219
Further company coverage: NDRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ENDRA Life Sciences
See all newsBrief: ENDRA Life Sciences - Enters First Amendment To Merger Agreement On October 1, 2026 - SEC Filing
ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger
Endra Life Sciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of 84 Cents A Share: Earnings Preview
Brief: ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences